Back to Search
Start Over
The Promising Effects of Erdosteine and Vitamin B in the Liver Ischemia/Reperfusion Model in Anesthetized Rats.
- Source :
-
Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2024 May 08; Vol. 60 (5). Date of Electronic Publication: 2024 May 08. - Publication Year :
- 2024
-
Abstract
- Background and Objectives: Erdosteine (Erd) is an antioxidant and anti-inflammatory drug. Vitamin B has been reported to exert anti-inflammatory and antioxidant effects. In this study, we investigated the effect of erdosteine and vitamin B complex on a liver ischemia/reperfusion (I/R) model. Materials and Methods: Thirty-two Wistar Albino male rats weighing 350-400 g were used. The animals were randomly selected and divided into four groups. The groups are as follows: first group (Sham), second group (I/R), third group (I/R + vit B), and fourth group (I/R + vit B + Erd). Rats were subjected to 45 min of hepatic ischemia, followed by a 45 min reperfusion period in the I/R and Vitamin B + Erd groups. An amount of 150 mg/kg/day of erdosteine was given orally for 2 days, and 0.05 mL/kg of i.p. vitamin B complex was given 30 min before the reperfusion. Serum biochemical parameters were measured. Serum Total Antioxidant Status (TAS) and Total Oxidant Status (TOS) were measured, and the Oxidative Stress Index (OSI) was calculated. Hepatic tissue samples were taken for the evaluation of histopathological features. Results : In terms of all histopathological parameters, there were significant differences in the I/R + vit B group and I/R + vit B + Erd group compared with the I/R group ( p < 0.01). In terms of aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH), TNF-alpha, and IL-6 levels, there were significant differences between the I/R group and treatment groups ( p < 0.01). The lowest TOS and OSI levels were obtained in the treatment groups, and these groups had statistically significantly higher TAS levels compared with the sham and I/R groups ( p < 0.01). Conclusions : As a preliminary experimental study, our study suggests that these agents may have potential diagnostic and therapeutic implications for both ischemic conditions and liver-related diseases. These results suggest that the combination of vit B + Erd may be used to protect against the devastating effects of I/R injury. Our study needs to be confirmed by clinical studies with large participation.
- Subjects :
- Animals
Male
Rats
Vitamin B Complex therapeutic use
Vitamin B Complex pharmacology
Aspartate Aminotransferases blood
Aspartate Aminotransferases analysis
Alanine Transaminase blood
Thioglycolates therapeutic use
Thioglycolates pharmacology
Reperfusion Injury drug therapy
Rats, Wistar
Thiophenes therapeutic use
Thiophenes pharmacology
Liver drug effects
Liver metabolism
Antioxidants therapeutic use
Antioxidants pharmacology
Disease Models, Animal
Oxidative Stress drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1648-9144
- Volume :
- 60
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Medicina (Kaunas, Lithuania)
- Publication Type :
- Academic Journal
- Accession number :
- 38792966
- Full Text :
- https://doi.org/10.3390/medicina60050783